Immunosuppressive effects of mesenchymal stem cells : involvement of HLA-G
INTRODUCTION: Mesenchymal stem cells (MSCs) possess unique immunomodulatory properties. They are able to suppress allogenic T-cell response and modify maturation of antigen-presenting cells. Their role in the treatment of severe graft versus host disease has been reported. The underlying molecular mechanisms of immunosuppression are currently being investigated. Histocompatibility locus antigen (HLA)-G is a nonclassical major histocompatibility complex class I antigen with strong immune-inhibitory properties.
METHODS: We studied the role of HLA-G on MSC-induced immunosuppression. The expression of HLA-G on human MSCs cultured alone and in mixed lymphocytes reaction (MSC/MLR) was analyzed.
RESULTS: We found that HLA-G can be detected on MSCs by real-time reverse-phase polymerase chain reaction, immunofluorescence, flow cytometry (52.4+/-3.6%), and enzyme-linked immunosorbent assay in the supernatant (38.7+/-5.2 ng/mL). HLA-G protein expression is constitutive and the level is not modified upon stimulation by allogenic lymphocytes in MSC/MLR. The functional role of HLA-G protein expressed by MSCs was analyzed using the 87G anti-HLA-G blocking antibody in a MSC/MLR. We found that blocking HLA-G molecule significantly raised lymphocyte proliferation in MSC/MLR (35.5%, P=0.01).
CONCLUSION: Our findings provide evidences supporting involvement of HLA-G in the immunosuppressive properties of MSCs. These results emphasize the potential application of MSCs as a relevant therapeutic candidate in transplantation.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2007 |
---|---|
Erschienen: |
2007 |
Enthalten in: |
Zur Gesamtaufnahme - volume:84 |
---|---|
Enthalten in: |
Transplantation - 84(2007), 2 vom: 27. Juli, Seite 231-7 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Nasef, Aisha [VerfasserIn] |
---|
Themen: |
HLA Antigens |
---|
Anmerkungen: |
Date Completed 28.08.2007 Date Revised 03.12.2021 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM17182430X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM17182430X | ||
003 | DE-627 | ||
005 | 20231223130509.0 | ||
007 | tu | ||
008 | 231223s2007 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0573.xml |
035 | |a (DE-627)NLM17182430X | ||
035 | |a (NLM)17667815 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Nasef, Aisha |e verfasserin |4 aut | |
245 | 1 | 0 | |a Immunosuppressive effects of mesenchymal stem cells |b involvement of HLA-G |
264 | 1 | |c 2007 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 28.08.2007 | ||
500 | |a Date Revised 03.12.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a INTRODUCTION: Mesenchymal stem cells (MSCs) possess unique immunomodulatory properties. They are able to suppress allogenic T-cell response and modify maturation of antigen-presenting cells. Their role in the treatment of severe graft versus host disease has been reported. The underlying molecular mechanisms of immunosuppression are currently being investigated. Histocompatibility locus antigen (HLA)-G is a nonclassical major histocompatibility complex class I antigen with strong immune-inhibitory properties | ||
520 | |a METHODS: We studied the role of HLA-G on MSC-induced immunosuppression. The expression of HLA-G on human MSCs cultured alone and in mixed lymphocytes reaction (MSC/MLR) was analyzed | ||
520 | |a RESULTS: We found that HLA-G can be detected on MSCs by real-time reverse-phase polymerase chain reaction, immunofluorescence, flow cytometry (52.4+/-3.6%), and enzyme-linked immunosorbent assay in the supernatant (38.7+/-5.2 ng/mL). HLA-G protein expression is constitutive and the level is not modified upon stimulation by allogenic lymphocytes in MSC/MLR. The functional role of HLA-G protein expressed by MSCs was analyzed using the 87G anti-HLA-G blocking antibody in a MSC/MLR. We found that blocking HLA-G molecule significantly raised lymphocyte proliferation in MSC/MLR (35.5%, P=0.01) | ||
520 | |a CONCLUSION: Our findings provide evidences supporting involvement of HLA-G in the immunosuppressive properties of MSCs. These results emphasize the potential application of MSCs as a relevant therapeutic candidate in transplantation | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a HLA Antigens |2 NLM | |
650 | 7 | |a HLA-G Antigens |2 NLM | |
650 | 7 | |a Histocompatibility Antigens Class I |2 NLM | |
650 | 7 | |a RNA, Messenger |2 NLM | |
700 | 1 | |a Mathieu, Noelle |e verfasserin |4 aut | |
700 | 1 | |a Chapel, Alain |e verfasserin |4 aut | |
700 | 1 | |a Frick, Johanna |e verfasserin |4 aut | |
700 | 1 | |a François, Sabine |e verfasserin |4 aut | |
700 | 1 | |a Mazurier, Christelle |e verfasserin |4 aut | |
700 | 1 | |a Boutarfa, Asma |e verfasserin |4 aut | |
700 | 1 | |a Bouchet, Sandrine |e verfasserin |4 aut | |
700 | 1 | |a Gorin, N-Claude |e verfasserin |4 aut | |
700 | 1 | |a Thierry, Dominique |e verfasserin |4 aut | |
700 | 1 | |a Fouillard, Loïc |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Transplantation |d 1963 |g 84(2007), 2 vom: 27. Juli, Seite 231-7 |w (DE-627)NLM000023787 |x 1534-6080 |7 nnns |
773 | 1 | 8 | |g volume:84 |g year:2007 |g number:2 |g day:27 |g month:07 |g pages:231-7 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 84 |j 2007 |e 2 |b 27 |c 07 |h 231-7 |